News | Neuro Imaging | May 10, 2018

Impaired Brain Pathways May Cause Attention Problems After Stroke

Patients with chronic stroke showed prolonged reaction time during imaging assessment

Impaired Brain Pathways May Cause Attention Problems After Stroke

May 10, 2018 — Damage to some of the pathways that carry information throughout the brain may be responsible for attention deficit in patients who have had a subcortical stroke in the brain's right hemisphere. These conclusions are drawn from a study published online in the journal Radiology. Researchers hope the findings may provide a measure for selecting suitable patients for early interventions aimed at reducing cognitive decline following stroke.

A stroke may affect cortical regions of the cerebral cortex, which includes the gray matter that lines the surface of the brain, or it may affect brain regions below the cortex, including white matter tracts connecting different regions of the brain. A stroke affecting brain structures below the cortex is known as a subcortical stroke.

More than one-third of patients experience cognitive decline after a stroke, including attention deficit, which can affect and impair the patient's ability to carry out routine activities of daily living.

"Impairment of attention has been observed in patients with both cortical and subcortical stroke," said senior study author Chunshui Yu, M.D., from the Department of Radiology at Tianjin Medical University General Hospital in Tianjin, China. "In cortical stroke, the direct involvement of cortical regions associated with attention may account for the deficit. However, the parts of the nervous and brain systems underlying attention deficit in subcortical stroke remain largely unknown."

To investigate the mechanisms underlying attention deficit in chronic subcortical stroke, Yu and colleagues combined voxel-based lesion-symptom mapping (VLSM) and diffusion tensor tractography (DTT) in two sets of patients: One group of 49 patients (32 men and 17 women between the ages of 40 and 71) after subcortical stroke, and 52 control patients (30 men and 22 women, age 40-68). VLSM is a method of analyzing relationships between tissue damage and behavioral deficits, and DTT is a magnetic resonance imaging (MRI) technique that allows for 3-D visualization of specific white matter tracts in the brain.

A modified version of the attention network test was used to assess visual attention function. VLSM was used to identify lesion locations related to attention deficit in the stroke patients. Then DTT was used to determine the responsible impaired brain connections at the chronic stage (> 6 months post-stroke).

The results showed that compared to the controls, patients with chronic stroke exhibited prolonged reaction time during the attention task. VLSM revealed that having an acute stroke lesion in the right caudate nucleus and nearby white matter was correlated to the prolonged reaction time. DTT showed that the responsible lesion was located in the right thalamic- and caudate-prefrontal pathways in controls.

The right brain damage subgroup had significantly decreased fractional anisotropy (FA) in these pathways, which were correlated with the prolonged reaction time. FA provides a way to measure diffusion occurring within a region of the brain. FA is typically higher in brain regions of high organization. Reductions in FA have been previously associated with advancing age and in cases of cognitive impairment.

"The impairment of the right thalamic- and caudate-prefrontal pathways was consistently associated with attention deficit in patients with right subcortical stroke," Yu said. "Based on this association, one can estimate which patients with stroke would be more likely to develop into long-term persisting attention deficit by evaluating the lesion-induced damage to these pathways."

For more information: www.pubs.rsna.org

 

Related Content

AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...